Browsing Tag
telehealth
12 posts
One pen, four doses, one month: Eli Lilly brings Zepbound KwikPen to Ro’s telehealth platform at $299
Eli Lilly (LLY) partners with Ro to launch the FDA-approved Zepbound KwikPen nationwide. What the $299 self-pay device means for the GLP-1 race. Read more.
What clinicians and regulators may question as GLP-1 therapies move into consumer health platforms
Discover how Hims & Hers and Novo Nordisk are reshaping GLP-1 access and what it means for pricing, regulation, and long-term care models.
HIMS near 52-week low as FDA issues 30 GLP-1 warning letters
FDA sends 30 warning letters to GLP-1 compounders, targeting Hims & Hers Health (HIMS) as regulatory and legal pressure intensifies. Read what it means for investors and the sector.
RD Nutrition Consultants acquired by Conscious Capital Growth and Petra Capital Partners in chronic care platform expansion
Private equity firms CCG and Petra Capital acquired RD Nutrition to scale chronic care and GLP-1 services. See what this signals for healthcare investors.
Telehealth distribution becomes central to 60 Degrees Pharmaceuticals’ malaria prevention execution plan
60 Degrees Pharmaceuticals partners with Runway Health to expand ARAKODA access. Explore what this telehealth shift means for growth and execution.
Hims & Hers targets preventive diagnostics with YourBio Health acquisition for pain-free blood sampling
Discover how Hims & Hers is reshaping preventive care by acquiring YourBio Health and bringing pain-free blood sampling into home-based diagnostics.
Mangoceuticals lands breakthrough partnership with Eli Lilly and Novo Nordisk to deliver low-cost GLP-1 care
Find out how Mangoceuticals’ partnership with Eli Lilly and Novo Nordisk could transform affordable access to Zepbound and Wegovy obesity treatments.
VSee Health wins three-year telehealth platform deal with leading Level 1 trauma and academic system
Discover how VSee Health’s three-year telehealth deal with a leading Level 1 trauma and academic system could transform enterprise virtual care delivery.
HHS grants VSee Health FedRAMP High ATO, clearing path for U.S. government telehealth adoption
Find out how VSee Health’s FedRAMP High ATO from HHS positions it to expand secure telehealth across U.S. federal agencies.
Why Hims & Hers Health’s new COO appointment matters as FDA scrutiny and growth collide
Hims & Hers Health (NASDAQ: HIMS) promotes Mike Chi to COO, consolidating leadership as it faces growth, regulation, and investor scrutiny in telehealth.